-
Browse Book Series
- Adhesion and Adhesives: Fundamental and Applied Aspects
- Advances in Additive Manufacturing Technologies
- Advances in Antenna, Microwave and Communication Engineering
- Advances in Biofeedstocks and Biofuels
- Advances in Cyber Security
- Advances in Data Engineering and Machine Learning
- Advances in Disease Diagnosis, Drug Delivery and Treatment
- Advances in E-Mobility
- Advances in Hydrogen Production and Storage
- Advances in Intelligent and Scientific Computing (AISC)
- Advances in Learning Analytics for Intelligent Cloud-IoT Systems
- Advances in Membrane Processes
- Advances in Nanotechnology and Applications
- Advances in Natural Gas Engineering
- Advances in Pipes and Pipelines
- Advances in Production Engineering
- Advances in Solar Cell Materials and Storage
- Advances in Surface Engineering and Materials Processing
- Applied Functional Materials
- Artificial Intelligence and Soft Computing for Industrial Transformation
- Astrobiology Perspectives on Life in the Universe
- Bioprocessing in Food Science
- Computational Intelligence and Biomedical Engineering
- Computational Intelligence in Industrial Mathematics
- Concise Introductions to AI and Data Science
- Cyber Systems and Quantum Engineering
- Decentralized Systems and Next-Generation Internet
- Diatoms: Biology and Applications
- Digital Convergence in Engineering Systems
- Emerging Trends in Medicinal and Pharmaceutical Chemistry
- Engineering Systems Design for Sustainable Development
- Fintech in a Sustainable Digital Society
- Human Centric Sustainability and Next Generation Technology
- Industry 5.0 Transformation Applications
- Infectious and Rare Diseases
- Innovations in Materials and Manufacturing
- Leading-Edge Breakthroughs in Artificial Intelligence
- Lifeline Molecules: Exploring Antioxidants and Their Impact
- Machine Learning in Biomedical Science and Healthcare Informatics
- Marine Nanoscience and Nanotechnology
- Materials Degradation and Failure
- Mathematics and Computer Science
- Next-Generation Computing and Communication Engineering
- Performability Engineering Series
- Robotics and Automation for Modern Applications
- Rotating Machinery Fundamentals and Advances
- Semiconductor Devices and Their Applications
- Separation Science
- Studies in Computational Intelligence and Smart Technologies
- Sustainable Biopolymer Technologies and Applications
- Sustainable Computing and Optimization
- Thermoplastic Bionanocomposites Series
- Transformative Innovations in Materials Science
Browse Subject Areas
For Authors
Submit a ProposalGenomics and Precision Healthcare
One Line Description
Unlock the future of individualized patient care with this guide to mastering the interdisciplinary synergy of next-generation sequencing, clinical diagnostics, and ethical frameworks that define the new era of precision medicine.
Audience
Students, researchers, and healthcare, biotechnology, and pharmaceutical professionals, and policymakers in genomics, molecular biology, and genetics.
Students, researchers, and healthcare, biotechnology, and pharmaceutical professionals, and policymakers in genomics, molecular biology, and genetics.
Description
The field of genomics has witnessed remarkable growth over the past few decades, fundamentally altering the landscape of healthcare and medical research. The rapid advancement of genomic technologies, particularly the development of next-generation sequencing and the growing understanding of the human genome, has opened up new frontiers in diagnostics, treatment, and prevention. Genomics now sits at the intersection of various disciplines, including molecular biology, bioinformatics, pharmacology, and clinical medicine, forming the foundation of precision healthcare. This book is a comprehensive exploration of the transformative impact of genomics on modern healthcare. It covers a broad range of topics, from the foundational principles of genetics and genomics to the cutting-edge applications of genomic technologies in clinical settings. The subject matter will provide readers with a thorough understanding of how genomic research is revolutionizing healthcare, with a particular focus on precision medicine, which tailors medical treatments based on individual genetic profiles. It will delve into the role of genomic technologies in diagnosing and treating various diseases, including cancer, rare diseases, and infectious diseases, while addressing how these innovations are shaping the future of healthcare delivery. A significant emphasis is placed on the challenges faced by healthcare professionals, researchers, and policymakers in integrating genomic data into everyday healthcare systems, including the implementation of genomic counseling, the ethical considerations of genetic testing, and the need for healthcare policy adaptation. This essential guide explores the global implications of genomic medicine, providing insights into the opportunities and challenges of implementing genomic healthcare worldwide.
Back to Top
The field of genomics has witnessed remarkable growth over the past few decades, fundamentally altering the landscape of healthcare and medical research. The rapid advancement of genomic technologies, particularly the development of next-generation sequencing and the growing understanding of the human genome, has opened up new frontiers in diagnostics, treatment, and prevention. Genomics now sits at the intersection of various disciplines, including molecular biology, bioinformatics, pharmacology, and clinical medicine, forming the foundation of precision healthcare. This book is a comprehensive exploration of the transformative impact of genomics on modern healthcare. It covers a broad range of topics, from the foundational principles of genetics and genomics to the cutting-edge applications of genomic technologies in clinical settings. The subject matter will provide readers with a thorough understanding of how genomic research is revolutionizing healthcare, with a particular focus on precision medicine, which tailors medical treatments based on individual genetic profiles. It will delve into the role of genomic technologies in diagnosing and treating various diseases, including cancer, rare diseases, and infectious diseases, while addressing how these innovations are shaping the future of healthcare delivery. A significant emphasis is placed on the challenges faced by healthcare professionals, researchers, and policymakers in integrating genomic data into everyday healthcare systems, including the implementation of genomic counseling, the ethical considerations of genetic testing, and the need for healthcare policy adaptation. This essential guide explores the global implications of genomic medicine, providing insights into the opportunities and challenges of implementing genomic healthcare worldwide.
Back to Top
Author / Editor Details
Swetha Kumari Koduru, PhD is a Scientist and Research Coordinator in the Department of Pharmaceutics and Pharmaceutical Technology at Kampala International University. She has internationally published more than 10 journal articles and book chapters. Her research interests include drug design, gene cloning, and agricultural entomology.
Swetha Kumari Koduru, PhD is a Scientist and Research Coordinator in the Department of Pharmaceutics and Pharmaceutical Technology at Kampala International University. She has internationally published more than 10 journal articles and book chapters. Her research interests include drug design, gene cloning, and agricultural entomology.
Sarad Pawar Naik Bukke, PhD is an Associate Professor and Research Coordinator in the Department of Pharmaceutics and Pharmaceutical Technology at Kampala International University with more than 12 years of experience. He has published more than 90 book chapters and articles in international journals. His research focuses on the formation of drug delivery, soil dispersions, bilayer tablets, and microsponges.
Hussaini Bello, PhD is a Professor in the Department of Pharmaceutics in the School of Pharmacy at the University of Wolverhampton. He has published five articles in international journals and conferences of repute. His research interests include drug discovery, pharmacology, and medicinal and pharmaceutical chemistry.
Muhamad Mustafa Mundu, PhD is the head of the Department of Electrical, Telecommunications and Computer Engineering in the School of Engineering and Applied Sciences at Kampala University. He has published one book and more than 45 articles in international journals and conferences. His research interests include renewable energy systems, energy storage, and satellites.
Ayush Madan, PhD is an Assistant Professor in the Department of Biotechnology in the School of Research and Technology at the People’s University in Bhanpur, India. He has published five books, more than 90 articles and book chapters, and one patent. His research interests include computational biology and informatics, nanobiotechnology, and bioprocess engineering.
Back to Top
Table of Contents
Preface
1. The Fundamentals of Genetics and Genomics: A Primer for Healthcare Professionals
K. Haripriya, Swetha Kumari Koduru and K. Nandini
1.1 Introduction
1.1.1 Definition of Genetics and Genomics
1.1.2 Importance in Modern Healthcare
1.1.2.1 Disease Diagnosis and Early Detection
1.1.2.2 Personalized and Precision Medicine
1.1.2.3 Risk Assessment and Prevention
1.1.2.4 Reproductive and Prenatal Health
1.1.2.5 Gene Therapy and Advanced Treatments
1.1.2.6 Infectious Disease Research and Vaccine Development
1.1.3 Historical Perspective
1.1.3.1 Early Observations and Theories in Genetics
1.1.3.2 The Rise of Classical Genetics
1.1.3.3 The Genomic Era and Modern Genetics
1.1.4 Precision Healthcare
1.1.4.1 Benefits of Precision Healthcare in Genetics and Genomics
1.2 Principles of Genetics
1.2.1 Genes and Chromosomes
1.2.1.1 Genes
1.2.1.2 Chromosomes
1.2.2 Mendelian Inheritance Patterns
1.2.2.1 Mendel’s Three Laws of Inheritance
1.2.2.2 Common Mendelian Inheritance Patterns
1.2.3 Non-Mendelian Inheritance (Epigenetics, Mitochondrial Inheritance)
1.2.3.1 Epigenetics: Changes in Gene Expression without DNA Alteration
1.2.3.2 Mitochondrial Inheritance: Maternal Inheritance
1.3 Genomic Technologies and Applications
1.3.1 Genomic Sequencing and Interpretation
1.3.1.1 Key Aspects
1.3.1.2 Applications
1.3.2 Genetic Testing (Types and Purposes)
1.3.3 Gene Therapy and CRISPR Technology
1.3.3.1 Types of Gene Therapy
1.3.3.2 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
1.3.4 Pharmacogenomics
1.4 Genetic Disorders and their Clinical Relevance
1.4.1 Single Gene Disorders
1.4.2 Chromosomal Abnormalities
1.4.3 Multifactorial and Complex Disorders
1.4.3.1 Key Characteristics
1.5 Genomics in Healthcare
1.5.1 Applications of Genomics in Healthcare
1.5.2 Future Directions for Genomics in Healthcare
1.5.2.1 Precision and Personalized Medicine for All
1.5.2.2 Widespread Genomic Screening in Healthy Individuals
1.5.2.3 Integration of Genomics into Electronic Health Records (EHRs)
1.5.2.4 Expansion of Gene Editing and Gene Therapy
1.5.2.5 AI and Big Data in Genomics
1.5.2.6 Global Genomic Initiatives and Equity
1.5.2.7 Polygenic Risk Scores (PRS)
1.5.2.8 Advances in Reproductive Genomics
1.5.2.9 Ethics, Regulation, and Data Privacy
1.5.2.10 Preventive and Predictive Genomics in Everyday Healthcare
1.6 Challenges and Limitations of Genomics and Precision Healthcare
1.6.1 Data Management and Analysis
1.6.2 Interpretation and Clinical Utility of Genomic Data
1.6.3 Ethical, Legal, and Social Implications (ELSI)
1.6.4 Access and Equity in Genomics and Precision Healthcare
1.6.5 Regulatory Frameworks and Policy Challenges
1.7 Role of Healthcare Professionals in Genetics and Genomics
1.7.1 Genetic Counseling and Patient Communication
1.7.2 Integrating Genomics into Clinical Practice
1.7.3 Future Trends in Personalized Medicine
1.8 Conclusion
1.8.1 Case Studies and Examples
1.8.2 Summary of Key Takeaways
1.8.3 Future Directions in Genetics and Genomics
References
2. From Gene Discovery to Clinical Applications: The Journey of Genomic Research
Bolaji Fatai Oyeyemi, Muhammad Abiodun Sulaiman, Saheedat Olabisi Dauda, Habeebat Adekilekun Oyewusi, Oluwatosin Olubunmi Oladipo and Habeebulahi Ajibola Adekilekun
2.1 Introduction
2.2 Historical Perspectives and Key Breakthroughs
2.3 Genomic Tools and Technologies
2.4 Integration of Multi-Omics Approaches
2.5 Clinical Applications of Genomic Research
2.6 Ethical, Legal, and Social Considerations
2.7 Case Studies and Clinical Success Stories
2.8 Future Directions and Challenges
2.9 Conclusion
References
3. Precision Medicine: Tailoring Treatments to Genetic Profiles
Ashok Thulluru, Goutham Yerrakula, Nawaz Mohammed, Reshma Tadipatri and Varun Srighakollapu
3.1 Introduction to Precision Medicine
3.1.1 Definition and Scope
3.1.2 Historical Context and Evolution
3.1.3 The Role of Genetic Profiling in Medicine
3.2 Genetic Profiling Technologies
3.2.1 Genomic Sequencing Techniques
3.2.1.1 Whole Genome Sequencing
3.2.1.2 Whole Exome Sequencing (WES)
3.2.1.3 Targeted Gene Sequencing
3.2.1.4 Next-Generation Sequencing
3.2.1.5 RNA Sequencing (RNA-Seq)
3.2.2 Modern Medicine and Genetic Markers/Biomarkers
3.2.2.1 Applications in the Diagnosis and Treatment of Diseases
3.2.2.2 Technological Advances
3.2.2.3 Challenges and Future Directions
3.2.3 Advances in CRISPR and Gene Editing
3.2.3.1 Higher Resolution and Productivity in Profiling
3.2.3.2 Applications and Future Directions
3.3 Key Mechanisms in Precision Medicine
3.4 Precision Medicine in Clinical Applications
3.5 Challenges and Ethical Concerns
3.6 The Future of Precision Medicine
3.6.1 Integration of AI and Machine Learning
3.6.2 The Role of Big Data in Enhancing Precision Medicine
3.6.3 Prospects of Global Genomic Databases
3.6.4 The Potential of Personalized Vaccines
3.7 Conclusion
References
4. Genomic Technologies in Diagnostic Medicine: Advances and Applications
Pradeep Natarajan
4.1 Introduction
4.1.1 Historical Background
4.1.2 Importance of Genomic Technologies in Personalized Medicine and Public Health
4.1.3 Current Challenges in Diagnostics
4.1.4 Overview of the Chapter
4.2 Fundamentals of Genomic Technologies
4.2.1 DNA Structure, Function, and Genetic Variation
4.2.2 Key Concepts: Gene, Genome, Transcriptome, Proteome
4.2.3 Genetic Mutations, SNPs, CNVs, and SVs
4.2.4 Epigenetic Modifications
4.2.5 Overview of Sequencing, Genotyping, and Gene Editing
4.3 Key Genomic Technologies
4.3.1 Next-Generation Sequencing (NGS)
4.3.2 Third-Generation Sequencing (PacBio, Oxford Nanopore)
4.3.3 Microarrays
4.3.4 CRISPR and Gene Editing Tools
4.3.5 PCR and Real-Time PCR
4.3.6 Single-Cell Genomics
4.3.7 Epigenomics Technologies
4.3.8 Spatial Transcriptomics
4.4 Applications in Diagnostic Medicine
4.4.1 Cancer Diagnostics
4.4.2 Infectious Disease Diagnostics
4.4.3 Inherited Genetic Disorders
4.4.4 Pharmacogenomics
4.4.5 Rare Diseases
4.4.6 Cardiovascular Diseases
4.4.7 Neurodegenerative Diseases
4.5 Challenges in Implementation
4.5.1 Technical Challenges
4.5.2 Ethical Concerns
4.5.3 Economic Issues
4.5.4 Infrastructure Needs
4.5.5 Data Storage and Management
4.5.6 Regulatory Hurdles
4.6 Emerging Trends and Future Directions
4.6.1 Advances in AI and Machine Learning
4.6.2 Integration of Multi-Omics
4.6.3 Real-Time Sequencing
4.6.4 Long-Read Sequencing Technologies
4.6.5 Synthetic Biology
4.6.6 Wearable Genomic Devices
4.6.7 Global Health Applications
4.7 Ethical, Legal, and Social Implications (ELSI)
4.7.1 Ethical Concerns in Prenatal Testing and Genome Editing
4.7.2 Legal Frameworks Governing Genetic Testing and Data Sharing
4.7.3 Social Implications
4.7.4 Genetic Discrimination
4.7.5 Cultural and Religious Perspectives
4.7.6 Informed Consent
4.8 Case Studies
4.8.1 Liquid Biopsy in Lung Cancer Diagnostics
4.8.2 NGS in Rare Diseases
4.8.3 Pharmacogenomics in Cardiology/Psychiatry
4.8.4 Infectious Disease Outbreaks
4.8.5 Polygenic Risk Scores
4.9 Summary and Key Takeaways
4.9.1 Summary of Advances in Genomic Technologies
4.9.2 Key Applications in Diagnostic Medicine
4.9.3 Future Directions
4.9.4 Call to Action
References
5. Pharmacogenomics: How Genetic Information Influences Drug Response
G. Avinash Kumar, P. Pravallika, V. Thirumalai, Chandrashekar Thalluri and Sarad Pawar Naik Bukke
5.1 Introduction
5.1.1 Definition and Scope
5.1.2 Evolution
5.1.3 Key Concepts
5.1.4 Relevance in Contemporary Medicine
5.2 Genetic Basis of Drug Response
5.2.1 Genetic Polymorphisms
5.2.1.1 Single Nucleotide Polymorphisms (SNPs)
5.2.1.2 Copy Number Variations (CNVs)
5.2.1.3 Insertions and Deletions (Indels)
5.2.1.4 Other Genetic Variations
5.2.2 Factors Causing Genetic Variations
5.2.2.1 Environmental and Toxins
5.2.2.2 The Influence of Lifestyle
5.3 Causal Relationship of Genetic Variations and Drug Response
5.3.1 Genetic Variations – Pharmacokinetics
5.3.1.1 Effects on Drug Absorption and Distribution
5.3.1.2 Effects on Drug Metabolism
5.3.1.3 Effects on Drug Elimination
5.3.2 Genetic Variations – Pharmacodynamics
5.3.2.1 Genetic Variability in Drug Receptors
5.3.2.2 Signal Transduction and Genetic Variability
5.4 Pharmacogenomics in Clinical Applications
5.4.1 Thiopurines
5.4.2 Clopidogrel
5.4.3 Carbamazepine
5.4.4 Herceptin (Trastuzumab) and HER2 Amplification
5.4.5 Abacavir and HLA-B*5701
5.4.6 Cetuximab and KRAS Mutations
5.4.7 Ivacaftor and CFTR Mutations
5.4.8 Other Drugs
5.4.9 Precision Oncology
5.4.9.1 Targeted Therapies in Oncology
5.4.9.2 Immune Checkpoint Inhibitors
5.5 Technologies in Pharmacogenomic Research
5.5.1 Genomic Sequencing Technologies
5.5.1.1 Next-Generation Sequencing (NGS)
5.5.1.2 Whole-Genome Sequencing (WGS)
5.5.1.3 Exome Sequencing
5.5.2 CRISPR
5.5.2.1 CRISPR and Gene Editing
5.5.2.2 CRISPR in Drug Testing
5.5.2.3 CRISPR in Personalized Therapies
5.5.3 Bioinformatics Tools
5.5.3.1 PharmGKB: Pharmacogenomics Database
5.5.3.2 dbSNP: Database of Single Nucleotide Polymorphisms
5.5.3.3 ClinVar: Clinically Relevant Variants
5.6 Drug Discovery and Development
5.6.1 Pharmacogenomics in Preclinical Drug Development
5.6.2 Clinical Trials
5.6.3 Regulatory Considerations
5.7 Pharmacogenomic Testing in Routine Clinical Practice
5.7.1 The DNA-Based Assays via POCT
5.7.2 Clinical Decision Support Systems (CDSS)
5.7.3 Challenges and Barriers to Implementation
5.8 International Initiatives and Collaborations
5.8.1 Major Global Pharmacogenomic Research Initiatives
5.8.2 Pharmacogenomics in Low-Resource Settings
5.9 Technological Advancements
5.9.1 Advances in Precision Medicine
5.9.2 Artificial Intelligence and Pharmacogenomics
5.10 Conclusion
References
6. Ethical, Legal, and Social Implications of Genomic Data in Healthcare
M. Reddy Sailaja, Swetha Kumari Koduru and R. Venkata Raghava Reddy
6.1 Introduction
6.1.1 The Promise of Genomics in Healthcare
6.1.2 The ELSI Imperative
6.2 Ethical Foundations
6.2.1 Respect for Autonomy and Informed Consent
6.2.1.1 Non-Discrimination
6.2.2 Justice and Equity in Access
6.2.3 Genetic and Genomic Testing (GGT)
6.3 Legal and Regulatory Frameworks
6.3.1 Data Privacy and Security
6.3.1.1 HIPAA: Protecting Health Information in the U.S.
6.3.1.2 GDPR: Comprehensive Protection in the EU
6.3.1.3 Emerging Frameworks and Initiatives
6.3.1.4 Protecting Genomic Data in Research and Clinical Settings
6.3.1.5 Balancing Data Sharing with Individual Privacy Rights
6.3.2 Genetic Discrimination and Anti-Discrimination Laws
6.3.2.1 Genetic Information Nondiscrimination Act (GINA)
6.3.2.2 Evaluating Effectiveness and Areas for Improvement
6.3.3 Intellectual Property Rights
6.3.3.1 Patenting of Genes and Genetic Tests: Societal, and Ethical Implications
6.3.3.2 Legal Developments
6.4 Social and Societal Implications of Genomic Technologies
6.4.1 Public Perceptions and Attitudes
6.4.1.1 Exploring Public Trust, Concerns, and Anxieties Regarding Genomic Technologies
6.4.1.2 Addressing Misinformation and Promoting Public Understanding of Genomics
6.4.1.3 The Role of Public Engagement and Dialogue in Shaping the Future of Genomic Medicine
6.4.2 Social and Psychological Impacts
6.4.2.1 The Impact of Genetic Information on Individual Identity, Family Relationships, and Social Interactions
6.4.2.2 Potential for Stigmatization and Discrimination Based on Genetic
Predispositions
6.4.2.3 Addressing the Psychological Impact of Receiving Genetic Test Results
6.4.3 Societal Implications
6.4.3.1 The Potential Impact of Genomics on Healthcare Systems, Healthcare Costs, and Public Health
6.4.3.2 Exploring the Societal Implications of Genetic Enhancement and Gene Editing Technologies
6.5 Conclusion
References
7. The Role of Genomics in Rare and Noncommunicable Diseases
S.K. Abdul Rahaman, Aman Sisodia, Ananda Kumar C.H., Padmavathi Sakinala and Ajay Bommareddy
7.1 Introduction
7.2 Need for Genomics in Disease Understanding
7.2.1 Role of Genomics in Medicine
7.2.2 Genomics in Precision Medicine
7.3 Genomic Technologies and their Applications
7.4 Tools and Methods for Genomic Analysis
7.5 Technological Advancements in Genomics
7.5.1 The Impact of Automation and Computational Tools on Large-Scale Genomic Studies
7.6 Genomics in Rare Diseases
7.7 Importance of Early Diagnosis
7.7.1 The Role of Genomics in Identifying Mutations
7.7.2 Genomics Technologies in Treatment of Rare Diseases
7.8 Discovery of New Disease Mechanisms
7.8.1 Genomics in Communicable Diseases
7.8.1.1 Genomic Research in Infectious Diseases
7.8.2 Advances in Genomic Technologies for Infectious Disease Surveillance
7.8.2.1 Genomic Tools for Targeted Therapies
7.8.2.2 Personalized Treatments According to Pathogen and Host Genetic Profiles
7.9 Genomics and Noncommunicable Diseases
7.9.1 Precision Medicine in Noncommunicable Diseases
7.9.2 Risk Detection and Prediction Using Genomics
7.9.3 Use of Genomic Screens in Risk Determination
7.9.3.1 Cardiovascular Diseases
7.9.3.2 Cancer
7.9.3.3 Diabetes
7.9.4 Biomarkers for Early Diagnosis
7.10 Ethical Concerns
7.10.1 Social Issues
7.10.2 Economic Issues
7.11 Need for Infrastructure and Accessibility
7.11.1 Integrating Genomic Data into Healthcare Systems
7.12 Gene Therapy and Future Directions
7.12.1 Gene Therapy for Rare and Infectious Diseases
7.12.2 Challenges and Recent Progress in Gene Therapy for Rare Diseases
7.12.3 Gene Editing Technologies: CRISPR-Cas9 and Its Applications
7.12.4 Emerging Trends in Genomic Medicine
7.13 Future Considerations and Challenges
7.14 Conclusion
References
8. Cancer Genomics: Innovations in Diagnosis, Prognosis and Therapy
Habeebulahi Ajibola Adekilekun, Olorunshola Dave Omodamiro, Ngozi Kalu Achi, Habeebat Adekilekun Oyewusi and Racheal Majekodunmi Omodamiro
8.1 Introduction
8.2 Emergence of Cancer Genomics Advances
8.3 Cancer Classification in the Genomic Age
8.4 The Genomics Role in Personalized Cancer Care
8.5 Innovations in Cancer Diagnosis
8.5.1 Next-Generation Sequencing (NGS) Tools
8.5.2 Genome-Wide Association Studies (GWAS)
8.5.3 Epigenetic Markers for Cancer Diagnosis/Epigenetic Alterations
8.5.4 Liquid Biopsy and Circulating Tumor DNA (ctDNA) Investigation
8.6 Diagnosis of Cancer with Subtypes Using Genomics
8.7 Advances in Cancer Prognosis
8.8 Precision Medicine and Targeted Therapies
8.9 Immunogenomics and Cancer Therapy
8.9.1 Neoantigen-Based Therapies
8.9.2 Cancer-Immune-Tumor Microenvironment
8.9.3 Cancer Genome-Derived Vaccine Development
8.9.4 Adoptive T-Cell Treatment and CAR-T Cells
8.10 Challenges and Limitations in Cancer Genomics
8.11 Future Perspectives
8.12 Conclusion
References
9. Genomic Research in Infectious Diseases: Impact and Advances
Ananda Kumar Chettupalli, Aman Sisodia, Rajendra Kumar Jadi, Akiful Haq and Nagarani Kagithala
9.1 Introduction
9.1.1 The Evolution of Infectious Disease Research
9.1.2 Genomics: A Game-Changer in Understanding Infections
9.1.3 Scope and Significance of the Chapter
9.2 Foundations of Genomic Technologies
9.2.1 Historical Overview of Genomics in Microbiology
9.2.2 Genomic Sequencing Platforms
9.2.2.1 Illumina Sequencing
9.2.2.2 Ion-Torrent Sequencing
9.2.2.3 PacBio Sequencing
9.2.2.4 Oxford Nanopore Sequencing
9.3 Overview of Bioinformatics Tools for Genomic Data Analysis
9.3.1 BLAST (Basic Local Alignment Search Tool)
9.3.2 Galaxy
9.3.3 Bowtie and Burrows-Wheeler Aligner (BWA)
9.3.4 Cufflinks
9.3.5 VEP (Variant Effect Predictor)
9.3.6 IGV (Integrative Genomics Viewer)
9.3.7 QIIME (Quantitative Insights into Microbial Ecology)
9.3.8 DeepVarant
9.4 Technological Advances in Genomic Research
9.4.1 Whole Genome Sequencing (WGS)
9.4.2 Metagenomics
9.4.3 Transcriptomics and Proteomics
9.4.4 CRISPR and Genome Editing Technologies
9.5 Understanding Pathogenesis through Genomics
9.5.1 Virulence Factors Identification
9.5.2 Molecular Mechanisms of Pathogenicity
9.6 Genomics in Disease Detection and Diagnosis
9.6.1 Next-Generation Diagnostics
9.6.2 Genomic Epidemiology
9.7 Human Genomics and Infectious Disease Susceptibility
9.7.1 Genetic Predisposition to Infections
9.7.2 Immune System Genomics
9.7.3 Pharmacogenomics in Infectious Diseases
9.8 Genomic Approaches to Vaccine Development
9.8.1 Genomic Data for Vaccine Design
9.8.2 Next-Generation Vaccines
9.9 Antimicrobial Resistance (AMR) and Genomics
9.9.1 Genomic Surveillance of AMR
9.9.2 Targeted Antibiotics and Resistance Mechanisms
9.10 Integrating Genomics with Traditional Epidemiological Approaches
9.10.1 Combining Genomic Tools with Classical Epidemiology for Enhanced Disease Tracking
9.10.2 The Role of Genomics in Understanding Disease Transmission Dynamics
9.10.3 Benefits of Integrating Genomics into Field-Based Epidemiological Studies
9.11 Pandemic Preparedness and Genomic Research
9.11.1 Real-Time Genomic Surveillance During Pandemics
9.11.2 Predictive Genomics in Preventing Disease Outbreaks
9.12 Challenges in Translating Genomic Discoveries into Clinical Applications
9.12.1 Regulatory and Ethical Hurdles
9.12.2 Challenges in Drug and Vaccine Development
9.12.3 Interdisciplinary Collaboration Needs
9.13 Innovative Genomic Approaches on the Horizon
9.13.1 Artificial Intelligence and Genomics
9.13.2 Pan-Genomics and Multi-Omics Approaches
9.13.3 Synthetic Biology and Infectious Disease Management
9.14 The Impact of Genomics on “One Health” Approaches to Infectious Diseases
9.14.1 Understanding the Interconnectedness of Human, Animal, and Environmental Health through Genomics
9.14.2 Genomic Surveillance in Animal Reservoirs and Environmental Sources of Infectious Diseases
9.14.3 Advancing “One Health” Strategies with Genomic Data to Prevent Cross-Species Transmission
9.15 The Role of Microbiome Genomics in Infectious Disease Prevention
9.15.1 Investigating the Human Microbiome’s Role in Infection Resistance and Susceptibility
9.15.2 Potential of Microbiome-Based Therapies and Vaccines in Infectious Disease Control
9.15.3 Genomic Approaches to Understanding the Relationship between Gut Microbiota and Infection
9.16 Personalized Medicine in Infectious Disease Treatment
9.16.1 The Impact of Genomic Sequencing on Individualized Therapeutic Strategies
9.16.2 Tailoring Drug Treatments Based on Genetic Profiles of Pathogens and Patients
9.16.3 Challenges and Opportunities in Implementing Personalized Medicine for Infectious Diseases
9.17 Global Collaboration in Genomic Research
9.17.1 International Genomic Initiatives
9.17.2 Data Sharing and Global Health Equity
9.18 Addressing Public Concerns Around Genomic Research in Infectious Diseases
9.18.1 Public Perception of Genomic Research
9.18.2 Addressing Fears Surrounding Gene Editing and the “Unknown” Consequences of Modifying Pathogens or Human Genomes
9.18.3 Misinformation and Genomic Research
9.18.4 Building Public Trust in Genomic Research
9.19 Exploring Genomic Approaches in Tropical and Neglected Diseases
9.19.1 Advancements in Genomic Research for Tropical Infectious Diseases
9.19.2 Genomic Innovations for Understanding and Addressing Neglected Diseases
9.20 Ethical, Legal, and Social Implications of Genomic Research
9.20.1 Genetic Privacy and the Protection of Personal Data in Research
9.20.2 Ethical Challenges in Genomic Editing and Pathogen Modification
9.20.3 Addressing Public Concerns Around Genomic Research in Infectious Diseases
9.21 Conclusion
References
10. Genomics of Prenatal and Paediatric Diseases: Early Detection and Intervention
Priyanka and Ayush Madan
10.1 Introduction
10.1.1 Overview of Genomics in Medicine
10.1.2 Importance of Early Detection and Intervention
10.2 Advancements in Genomic Technologies
10.2.1 Whole-Genome Sequencing (WGS)
10.2.2 Non-Invasive Prenatal Testing (NIPT)
10.2.3 Genetic Screening Tools for Paediatric Diseases
10.2.4 Others
10.3 Prenatal Genomic Screening
10.3.1 Used Techniques and Methods
10.3.2 Applications and Benefits of Clinical Usage
10.3.3 Ethical Considerations
10.4 Paediatric Genomics: Early Detection of Genetic Disorders
10.4.1 Common Paediatric Genetic Disorders
10.4.2 Role of Genomics in Preventive Paediatric Care
10.5 Personalized Medicine and Targeted Interventions
10.5.1 Needed Therapeutic Approaches for Desired Results
10.5.2 Impact of Early Genetic Detection on Treatment
10.6 Challenges in Genomic Implementation
10.6.1 Ethical and Psychological Implications of Genomic Implementation
10.6.2 Accessibility and Equity in Genomic Medicine
10.6.3 Cost-Effectiveness of Genomic Screening Programs
10.7 Future Directions and Innovations
10.7.1 Emerging Genomic Technologies
10.7.2 The Role of Artificial Intelligence and Big Data
10.7.3 Genomic Counselling and Education
10.8 Conclusion
10.8.1 The Future of Genomics in Prenatal and Paediatric Medicine
References
11. Integrating Genomic Data into Electronic Health Records (EHRs)
Raju C., Thrisha Lakkireddy, Reddi Mohan Naidu K., Sivasubramanyam Medasani and Bukke Pasunath Naik
11.1 Introduction
11.2 EHRs: Structure and Standards
11.2.1 Data Structure in EHRs
11.2.1.1 Structured Data
11.2.1.2 Unstructured Data
11.2.1.3 Hybrid Data Models
11.2.2 Standardization Protocols
11.2.2.1 Health Level Seven (HL7) Standards
11.2.2.2 Observational Medical Outcomes Partnership (OMOP) Common Data
Model
11.2.2.3 Digital Imaging and Communications in Medicine (DICOM)
11.2.2.4 Logical Observation Identifiers Names and Codes (LOINC)
11.2.2.5 RxNorm
11.2.3 Terminology Standards
11.2.3.1 SNOMED CT (Systematized Nomenclature of Medicine – Clinical Terms)
11.2.3.2 ICD-10 (International Classification of Diseases, 10th Revision)
11.2.3.3 Unified Medical Language System (UMLS)
11.2.4 Interoperability Solutions
11.2.4.1 Semantic Interoperability
11.2.4.2 Syntactic Interoperability
11.2.4.3 Interoperability Frameworks and Networks
11.2.4.4 Application Programming Interfaces (APIs)
11.2.4.5 Health Information Exchanges (HIEs)
11.2.4.6 Cloud-Based Interoperability Solutions
11.3 Genomics and Impact in Medicine
11.4 AI and ML in Integration of Genomic Data in EHRs
11.5 Technical Challenges in Integrating Genetic Data within Current EHRs
11.6 Conclusion
References
12. Genomic Counseling: Navigating the Complexities of Genetic Risk and Inheritance
Mudigubba Manoj Kumar, Queeni Sharoon Melam, Mohammed Azhar Hussain, Vishnuvara V. Tummeeti and Akkiraju Sudheer
12.1 Introduction to Genetic Counseling
12.2 Genetic Risk Assessment
12.3 The Counseling Process
12.4 Applications of Genetic Counseling
Conclusion
References
13. Healthcare Policy and Genomics: Shaping the Future of Health Care Systems
A. Revathi, B. Princy, K. Janani, M. Divya, B. Lokeshwari and P. Saranraj
13.1 Introduction
13.2 Genomic Public Health Care
13.3 COVID-19 Pandemic Healthcare
13.4 Impact of Genomics on Personalized Medicine
13.5 Genomics in Disease Prevention and Public Health
13.6 Integration of Genomics into Healthcare Systems
13.7 Genomic Research for Humans
13.8 AI in Healthcare
13.9 AI Applications in Healthcare
13.9.1 Medical Imaging Analysis
13.9.2 Drug Discovery
13.9.3 Precision Medicine
13.10 Challenges Posed by the Use of AI in Healthcare
13.11 Future Challenges in Healthcare
13.12 Conclusion
References
14. Patient Perspectives and Experiences with Genomic Testing
Safa A. Abdalla
14.1 Introduction
14.2 The Use of Genetic Testing to Screen for Diseases
14.3 Patient Understanding and Knowledge
14.4 Perception of Patients towards Genetic Testing
14.5 Barriers against Pharmacogenomics Testing
14.6 Incidental Findings
14.7 Perceptions towards Prenatal Genetic Testing
14.8 Perception towards Genetic Testing for Cancer
14.9 Perception towards Genetic Testing for Neurological Degenerative and Psychiatric Diseases
14.10 Perception towards Genetic Testing for Other Diseases
14.11 Conclusion
Abbreviations
References
15. Global Prospectives on Genomic Healthcare: Opportunities and Challenges
Shaik Harun Rasheed, Kondapuram Parameshwar, G. Buela Priyanka, Laith Hamza Samein and Ravi Kumar Vakkalagadda
Abbreviations
15.1 Introduction
15.1.1 Scope
15.1.2 Importance and Impact
15.2 Historical Development of Genomic Medicine
15.2.1 Key Milestones
15.3 Current Applications of Genomic Healthcare
15.3.1 Precision Medicine
15.4 Ethical, Legal, and Social Implications of Genomic Healthcare
15.4.1 Privacy and Data Security
15.5 Global Initiatives and Policies in Genomic Healthcare
15.5.1 International Collaborations
15.6 Technological Advancements in Genomic Healthcare
15.6.1 CRISPR-Cas9 Technology
15.7 Challenges and Limitations in Genomic Healthcare
15.7.1 Access and Equity
15.8 Future Directions and Emerging Trends in Genomic Healthcare
15.8.1 Personalized Therapies
15.9 Conclusion
Acknowledgment
References
Index
Back to Top
Preface
1. The Fundamentals of Genetics and Genomics: A Primer for Healthcare Professionals
K. Haripriya, Swetha Kumari Koduru and K. Nandini
1.1 Introduction
1.1.1 Definition of Genetics and Genomics
1.1.2 Importance in Modern Healthcare
1.1.2.1 Disease Diagnosis and Early Detection
1.1.2.2 Personalized and Precision Medicine
1.1.2.3 Risk Assessment and Prevention
1.1.2.4 Reproductive and Prenatal Health
1.1.2.5 Gene Therapy and Advanced Treatments
1.1.2.6 Infectious Disease Research and Vaccine Development
1.1.3 Historical Perspective
1.1.3.1 Early Observations and Theories in Genetics
1.1.3.2 The Rise of Classical Genetics
1.1.3.3 The Genomic Era and Modern Genetics
1.1.4 Precision Healthcare
1.1.4.1 Benefits of Precision Healthcare in Genetics and Genomics
1.2 Principles of Genetics
1.2.1 Genes and Chromosomes
1.2.1.1 Genes
1.2.1.2 Chromosomes
1.2.2 Mendelian Inheritance Patterns
1.2.2.1 Mendel’s Three Laws of Inheritance
1.2.2.2 Common Mendelian Inheritance Patterns
1.2.3 Non-Mendelian Inheritance (Epigenetics, Mitochondrial Inheritance)
1.2.3.1 Epigenetics: Changes in Gene Expression without DNA Alteration
1.2.3.2 Mitochondrial Inheritance: Maternal Inheritance
1.3 Genomic Technologies and Applications
1.3.1 Genomic Sequencing and Interpretation
1.3.1.1 Key Aspects
1.3.1.2 Applications
1.3.2 Genetic Testing (Types and Purposes)
1.3.3 Gene Therapy and CRISPR Technology
1.3.3.1 Types of Gene Therapy
1.3.3.2 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
1.3.4 Pharmacogenomics
1.4 Genetic Disorders and their Clinical Relevance
1.4.1 Single Gene Disorders
1.4.2 Chromosomal Abnormalities
1.4.3 Multifactorial and Complex Disorders
1.4.3.1 Key Characteristics
1.5 Genomics in Healthcare
1.5.1 Applications of Genomics in Healthcare
1.5.2 Future Directions for Genomics in Healthcare
1.5.2.1 Precision and Personalized Medicine for All
1.5.2.2 Widespread Genomic Screening in Healthy Individuals
1.5.2.3 Integration of Genomics into Electronic Health Records (EHRs)
1.5.2.4 Expansion of Gene Editing and Gene Therapy
1.5.2.5 AI and Big Data in Genomics
1.5.2.6 Global Genomic Initiatives and Equity
1.5.2.7 Polygenic Risk Scores (PRS)
1.5.2.8 Advances in Reproductive Genomics
1.5.2.9 Ethics, Regulation, and Data Privacy
1.5.2.10 Preventive and Predictive Genomics in Everyday Healthcare
1.6 Challenges and Limitations of Genomics and Precision Healthcare
1.6.1 Data Management and Analysis
1.6.2 Interpretation and Clinical Utility of Genomic Data
1.6.3 Ethical, Legal, and Social Implications (ELSI)
1.6.4 Access and Equity in Genomics and Precision Healthcare
1.6.5 Regulatory Frameworks and Policy Challenges
1.7 Role of Healthcare Professionals in Genetics and Genomics
1.7.1 Genetic Counseling and Patient Communication
1.7.2 Integrating Genomics into Clinical Practice
1.7.3 Future Trends in Personalized Medicine
1.8 Conclusion
1.8.1 Case Studies and Examples
1.8.2 Summary of Key Takeaways
1.8.3 Future Directions in Genetics and Genomics
References
2. From Gene Discovery to Clinical Applications: The Journey of Genomic Research
Bolaji Fatai Oyeyemi, Muhammad Abiodun Sulaiman, Saheedat Olabisi Dauda, Habeebat Adekilekun Oyewusi, Oluwatosin Olubunmi Oladipo and Habeebulahi Ajibola Adekilekun
2.1 Introduction
2.2 Historical Perspectives and Key Breakthroughs
2.3 Genomic Tools and Technologies
2.4 Integration of Multi-Omics Approaches
2.5 Clinical Applications of Genomic Research
2.6 Ethical, Legal, and Social Considerations
2.7 Case Studies and Clinical Success Stories
2.8 Future Directions and Challenges
2.9 Conclusion
References
3. Precision Medicine: Tailoring Treatments to Genetic Profiles
Ashok Thulluru, Goutham Yerrakula, Nawaz Mohammed, Reshma Tadipatri and Varun Srighakollapu
3.1 Introduction to Precision Medicine
3.1.1 Definition and Scope
3.1.2 Historical Context and Evolution
3.1.3 The Role of Genetic Profiling in Medicine
3.2 Genetic Profiling Technologies
3.2.1 Genomic Sequencing Techniques
3.2.1.1 Whole Genome Sequencing
3.2.1.2 Whole Exome Sequencing (WES)
3.2.1.3 Targeted Gene Sequencing
3.2.1.4 Next-Generation Sequencing
3.2.1.5 RNA Sequencing (RNA-Seq)
3.2.2 Modern Medicine and Genetic Markers/Biomarkers
3.2.2.1 Applications in the Diagnosis and Treatment of Diseases
3.2.2.2 Technological Advances
3.2.2.3 Challenges and Future Directions
3.2.3 Advances in CRISPR and Gene Editing
3.2.3.1 Higher Resolution and Productivity in Profiling
3.2.3.2 Applications and Future Directions
3.3 Key Mechanisms in Precision Medicine
3.4 Precision Medicine in Clinical Applications
3.5 Challenges and Ethical Concerns
3.6 The Future of Precision Medicine
3.6.1 Integration of AI and Machine Learning
3.6.2 The Role of Big Data in Enhancing Precision Medicine
3.6.3 Prospects of Global Genomic Databases
3.6.4 The Potential of Personalized Vaccines
3.7 Conclusion
References
4. Genomic Technologies in Diagnostic Medicine: Advances and Applications
Pradeep Natarajan
4.1 Introduction
4.1.1 Historical Background
4.1.2 Importance of Genomic Technologies in Personalized Medicine and Public Health
4.1.3 Current Challenges in Diagnostics
4.1.4 Overview of the Chapter
4.2 Fundamentals of Genomic Technologies
4.2.1 DNA Structure, Function, and Genetic Variation
4.2.2 Key Concepts: Gene, Genome, Transcriptome, Proteome
4.2.3 Genetic Mutations, SNPs, CNVs, and SVs
4.2.4 Epigenetic Modifications
4.2.5 Overview of Sequencing, Genotyping, and Gene Editing
4.3 Key Genomic Technologies
4.3.1 Next-Generation Sequencing (NGS)
4.3.2 Third-Generation Sequencing (PacBio, Oxford Nanopore)
4.3.3 Microarrays
4.3.4 CRISPR and Gene Editing Tools
4.3.5 PCR and Real-Time PCR
4.3.6 Single-Cell Genomics
4.3.7 Epigenomics Technologies
4.3.8 Spatial Transcriptomics
4.4 Applications in Diagnostic Medicine
4.4.1 Cancer Diagnostics
4.4.2 Infectious Disease Diagnostics
4.4.3 Inherited Genetic Disorders
4.4.4 Pharmacogenomics
4.4.5 Rare Diseases
4.4.6 Cardiovascular Diseases
4.4.7 Neurodegenerative Diseases
4.5 Challenges in Implementation
4.5.1 Technical Challenges
4.5.2 Ethical Concerns
4.5.3 Economic Issues
4.5.4 Infrastructure Needs
4.5.5 Data Storage and Management
4.5.6 Regulatory Hurdles
4.6 Emerging Trends and Future Directions
4.6.1 Advances in AI and Machine Learning
4.6.2 Integration of Multi-Omics
4.6.3 Real-Time Sequencing
4.6.4 Long-Read Sequencing Technologies
4.6.5 Synthetic Biology
4.6.6 Wearable Genomic Devices
4.6.7 Global Health Applications
4.7 Ethical, Legal, and Social Implications (ELSI)
4.7.1 Ethical Concerns in Prenatal Testing and Genome Editing
4.7.2 Legal Frameworks Governing Genetic Testing and Data Sharing
4.7.3 Social Implications
4.7.4 Genetic Discrimination
4.7.5 Cultural and Religious Perspectives
4.7.6 Informed Consent
4.8 Case Studies
4.8.1 Liquid Biopsy in Lung Cancer Diagnostics
4.8.2 NGS in Rare Diseases
4.8.3 Pharmacogenomics in Cardiology/Psychiatry
4.8.4 Infectious Disease Outbreaks
4.8.5 Polygenic Risk Scores
4.9 Summary and Key Takeaways
4.9.1 Summary of Advances in Genomic Technologies
4.9.2 Key Applications in Diagnostic Medicine
4.9.3 Future Directions
4.9.4 Call to Action
References
5. Pharmacogenomics: How Genetic Information Influences Drug Response
G. Avinash Kumar, P. Pravallika, V. Thirumalai, Chandrashekar Thalluri and Sarad Pawar Naik Bukke
5.1 Introduction
5.1.1 Definition and Scope
5.1.2 Evolution
5.1.3 Key Concepts
5.1.4 Relevance in Contemporary Medicine
5.2 Genetic Basis of Drug Response
5.2.1 Genetic Polymorphisms
5.2.1.1 Single Nucleotide Polymorphisms (SNPs)
5.2.1.2 Copy Number Variations (CNVs)
5.2.1.3 Insertions and Deletions (Indels)
5.2.1.4 Other Genetic Variations
5.2.2 Factors Causing Genetic Variations
5.2.2.1 Environmental and Toxins
5.2.2.2 The Influence of Lifestyle
5.3 Causal Relationship of Genetic Variations and Drug Response
5.3.1 Genetic Variations – Pharmacokinetics
5.3.1.1 Effects on Drug Absorption and Distribution
5.3.1.2 Effects on Drug Metabolism
5.3.1.3 Effects on Drug Elimination
5.3.2 Genetic Variations – Pharmacodynamics
5.3.2.1 Genetic Variability in Drug Receptors
5.3.2.2 Signal Transduction and Genetic Variability
5.4 Pharmacogenomics in Clinical Applications
5.4.1 Thiopurines
5.4.2 Clopidogrel
5.4.3 Carbamazepine
5.4.4 Herceptin (Trastuzumab) and HER2 Amplification
5.4.5 Abacavir and HLA-B*5701
5.4.6 Cetuximab and KRAS Mutations
5.4.7 Ivacaftor and CFTR Mutations
5.4.8 Other Drugs
5.4.9 Precision Oncology
5.4.9.1 Targeted Therapies in Oncology
5.4.9.2 Immune Checkpoint Inhibitors
5.5 Technologies in Pharmacogenomic Research
5.5.1 Genomic Sequencing Technologies
5.5.1.1 Next-Generation Sequencing (NGS)
5.5.1.2 Whole-Genome Sequencing (WGS)
5.5.1.3 Exome Sequencing
5.5.2 CRISPR
5.5.2.1 CRISPR and Gene Editing
5.5.2.2 CRISPR in Drug Testing
5.5.2.3 CRISPR in Personalized Therapies
5.5.3 Bioinformatics Tools
5.5.3.1 PharmGKB: Pharmacogenomics Database
5.5.3.2 dbSNP: Database of Single Nucleotide Polymorphisms
5.5.3.3 ClinVar: Clinically Relevant Variants
5.6 Drug Discovery and Development
5.6.1 Pharmacogenomics in Preclinical Drug Development
5.6.2 Clinical Trials
5.6.3 Regulatory Considerations
5.7 Pharmacogenomic Testing in Routine Clinical Practice
5.7.1 The DNA-Based Assays via POCT
5.7.2 Clinical Decision Support Systems (CDSS)
5.7.3 Challenges and Barriers to Implementation
5.8 International Initiatives and Collaborations
5.8.1 Major Global Pharmacogenomic Research Initiatives
5.8.2 Pharmacogenomics in Low-Resource Settings
5.9 Technological Advancements
5.9.1 Advances in Precision Medicine
5.9.2 Artificial Intelligence and Pharmacogenomics
5.10 Conclusion
References
6. Ethical, Legal, and Social Implications of Genomic Data in Healthcare
M. Reddy Sailaja, Swetha Kumari Koduru and R. Venkata Raghava Reddy
6.1 Introduction
6.1.1 The Promise of Genomics in Healthcare
6.1.2 The ELSI Imperative
6.2 Ethical Foundations
6.2.1 Respect for Autonomy and Informed Consent
6.2.1.1 Non-Discrimination
6.2.2 Justice and Equity in Access
6.2.3 Genetic and Genomic Testing (GGT)
6.3 Legal and Regulatory Frameworks
6.3.1 Data Privacy and Security
6.3.1.1 HIPAA: Protecting Health Information in the U.S.
6.3.1.2 GDPR: Comprehensive Protection in the EU
6.3.1.3 Emerging Frameworks and Initiatives
6.3.1.4 Protecting Genomic Data in Research and Clinical Settings
6.3.1.5 Balancing Data Sharing with Individual Privacy Rights
6.3.2 Genetic Discrimination and Anti-Discrimination Laws
6.3.2.1 Genetic Information Nondiscrimination Act (GINA)
6.3.2.2 Evaluating Effectiveness and Areas for Improvement
6.3.3 Intellectual Property Rights
6.3.3.1 Patenting of Genes and Genetic Tests: Societal, and Ethical Implications
6.3.3.2 Legal Developments
6.4 Social and Societal Implications of Genomic Technologies
6.4.1 Public Perceptions and Attitudes
6.4.1.1 Exploring Public Trust, Concerns, and Anxieties Regarding Genomic Technologies
6.4.1.2 Addressing Misinformation and Promoting Public Understanding of Genomics
6.4.1.3 The Role of Public Engagement and Dialogue in Shaping the Future of Genomic Medicine
6.4.2 Social and Psychological Impacts
6.4.2.1 The Impact of Genetic Information on Individual Identity, Family Relationships, and Social Interactions
6.4.2.2 Potential for Stigmatization and Discrimination Based on Genetic
Predispositions
6.4.2.3 Addressing the Psychological Impact of Receiving Genetic Test Results
6.4.3 Societal Implications
6.4.3.1 The Potential Impact of Genomics on Healthcare Systems, Healthcare Costs, and Public Health
6.4.3.2 Exploring the Societal Implications of Genetic Enhancement and Gene Editing Technologies
6.5 Conclusion
References
7. The Role of Genomics in Rare and Noncommunicable Diseases
S.K. Abdul Rahaman, Aman Sisodia, Ananda Kumar C.H., Padmavathi Sakinala and Ajay Bommareddy
7.1 Introduction
7.2 Need for Genomics in Disease Understanding
7.2.1 Role of Genomics in Medicine
7.2.2 Genomics in Precision Medicine
7.3 Genomic Technologies and their Applications
7.4 Tools and Methods for Genomic Analysis
7.5 Technological Advancements in Genomics
7.5.1 The Impact of Automation and Computational Tools on Large-Scale Genomic Studies
7.6 Genomics in Rare Diseases
7.7 Importance of Early Diagnosis
7.7.1 The Role of Genomics in Identifying Mutations
7.7.2 Genomics Technologies in Treatment of Rare Diseases
7.8 Discovery of New Disease Mechanisms
7.8.1 Genomics in Communicable Diseases
7.8.1.1 Genomic Research in Infectious Diseases
7.8.2 Advances in Genomic Technologies for Infectious Disease Surveillance
7.8.2.1 Genomic Tools for Targeted Therapies
7.8.2.2 Personalized Treatments According to Pathogen and Host Genetic Profiles
7.9 Genomics and Noncommunicable Diseases
7.9.1 Precision Medicine in Noncommunicable Diseases
7.9.2 Risk Detection and Prediction Using Genomics
7.9.3 Use of Genomic Screens in Risk Determination
7.9.3.1 Cardiovascular Diseases
7.9.3.2 Cancer
7.9.3.3 Diabetes
7.9.4 Biomarkers for Early Diagnosis
7.10 Ethical Concerns
7.10.1 Social Issues
7.10.2 Economic Issues
7.11 Need for Infrastructure and Accessibility
7.11.1 Integrating Genomic Data into Healthcare Systems
7.12 Gene Therapy and Future Directions
7.12.1 Gene Therapy for Rare and Infectious Diseases
7.12.2 Challenges and Recent Progress in Gene Therapy for Rare Diseases
7.12.3 Gene Editing Technologies: CRISPR-Cas9 and Its Applications
7.12.4 Emerging Trends in Genomic Medicine
7.13 Future Considerations and Challenges
7.14 Conclusion
References
8. Cancer Genomics: Innovations in Diagnosis, Prognosis and Therapy
Habeebulahi Ajibola Adekilekun, Olorunshola Dave Omodamiro, Ngozi Kalu Achi, Habeebat Adekilekun Oyewusi and Racheal Majekodunmi Omodamiro
8.1 Introduction
8.2 Emergence of Cancer Genomics Advances
8.3 Cancer Classification in the Genomic Age
8.4 The Genomics Role in Personalized Cancer Care
8.5 Innovations in Cancer Diagnosis
8.5.1 Next-Generation Sequencing (NGS) Tools
8.5.2 Genome-Wide Association Studies (GWAS)
8.5.3 Epigenetic Markers for Cancer Diagnosis/Epigenetic Alterations
8.5.4 Liquid Biopsy and Circulating Tumor DNA (ctDNA) Investigation
8.6 Diagnosis of Cancer with Subtypes Using Genomics
8.7 Advances in Cancer Prognosis
8.8 Precision Medicine and Targeted Therapies
8.9 Immunogenomics and Cancer Therapy
8.9.1 Neoantigen-Based Therapies
8.9.2 Cancer-Immune-Tumor Microenvironment
8.9.3 Cancer Genome-Derived Vaccine Development
8.9.4 Adoptive T-Cell Treatment and CAR-T Cells
8.10 Challenges and Limitations in Cancer Genomics
8.11 Future Perspectives
8.12 Conclusion
References
9. Genomic Research in Infectious Diseases: Impact and Advances
Ananda Kumar Chettupalli, Aman Sisodia, Rajendra Kumar Jadi, Akiful Haq and Nagarani Kagithala
9.1 Introduction
9.1.1 The Evolution of Infectious Disease Research
9.1.2 Genomics: A Game-Changer in Understanding Infections
9.1.3 Scope and Significance of the Chapter
9.2 Foundations of Genomic Technologies
9.2.1 Historical Overview of Genomics in Microbiology
9.2.2 Genomic Sequencing Platforms
9.2.2.1 Illumina Sequencing
9.2.2.2 Ion-Torrent Sequencing
9.2.2.3 PacBio Sequencing
9.2.2.4 Oxford Nanopore Sequencing
9.3 Overview of Bioinformatics Tools for Genomic Data Analysis
9.3.1 BLAST (Basic Local Alignment Search Tool)
9.3.2 Galaxy
9.3.3 Bowtie and Burrows-Wheeler Aligner (BWA)
9.3.4 Cufflinks
9.3.5 VEP (Variant Effect Predictor)
9.3.6 IGV (Integrative Genomics Viewer)
9.3.7 QIIME (Quantitative Insights into Microbial Ecology)
9.3.8 DeepVarant
9.4 Technological Advances in Genomic Research
9.4.1 Whole Genome Sequencing (WGS)
9.4.2 Metagenomics
9.4.3 Transcriptomics and Proteomics
9.4.4 CRISPR and Genome Editing Technologies
9.5 Understanding Pathogenesis through Genomics
9.5.1 Virulence Factors Identification
9.5.2 Molecular Mechanisms of Pathogenicity
9.6 Genomics in Disease Detection and Diagnosis
9.6.1 Next-Generation Diagnostics
9.6.2 Genomic Epidemiology
9.7 Human Genomics and Infectious Disease Susceptibility
9.7.1 Genetic Predisposition to Infections
9.7.2 Immune System Genomics
9.7.3 Pharmacogenomics in Infectious Diseases
9.8 Genomic Approaches to Vaccine Development
9.8.1 Genomic Data for Vaccine Design
9.8.2 Next-Generation Vaccines
9.9 Antimicrobial Resistance (AMR) and Genomics
9.9.1 Genomic Surveillance of AMR
9.9.2 Targeted Antibiotics and Resistance Mechanisms
9.10 Integrating Genomics with Traditional Epidemiological Approaches
9.10.1 Combining Genomic Tools with Classical Epidemiology for Enhanced Disease Tracking
9.10.2 The Role of Genomics in Understanding Disease Transmission Dynamics
9.10.3 Benefits of Integrating Genomics into Field-Based Epidemiological Studies
9.11 Pandemic Preparedness and Genomic Research
9.11.1 Real-Time Genomic Surveillance During Pandemics
9.11.2 Predictive Genomics in Preventing Disease Outbreaks
9.12 Challenges in Translating Genomic Discoveries into Clinical Applications
9.12.1 Regulatory and Ethical Hurdles
9.12.2 Challenges in Drug and Vaccine Development
9.12.3 Interdisciplinary Collaboration Needs
9.13 Innovative Genomic Approaches on the Horizon
9.13.1 Artificial Intelligence and Genomics
9.13.2 Pan-Genomics and Multi-Omics Approaches
9.13.3 Synthetic Biology and Infectious Disease Management
9.14 The Impact of Genomics on “One Health” Approaches to Infectious Diseases
9.14.1 Understanding the Interconnectedness of Human, Animal, and Environmental Health through Genomics
9.14.2 Genomic Surveillance in Animal Reservoirs and Environmental Sources of Infectious Diseases
9.14.3 Advancing “One Health” Strategies with Genomic Data to Prevent Cross-Species Transmission
9.15 The Role of Microbiome Genomics in Infectious Disease Prevention
9.15.1 Investigating the Human Microbiome’s Role in Infection Resistance and Susceptibility
9.15.2 Potential of Microbiome-Based Therapies and Vaccines in Infectious Disease Control
9.15.3 Genomic Approaches to Understanding the Relationship between Gut Microbiota and Infection
9.16 Personalized Medicine in Infectious Disease Treatment
9.16.1 The Impact of Genomic Sequencing on Individualized Therapeutic Strategies
9.16.2 Tailoring Drug Treatments Based on Genetic Profiles of Pathogens and Patients
9.16.3 Challenges and Opportunities in Implementing Personalized Medicine for Infectious Diseases
9.17 Global Collaboration in Genomic Research
9.17.1 International Genomic Initiatives
9.17.2 Data Sharing and Global Health Equity
9.18 Addressing Public Concerns Around Genomic Research in Infectious Diseases
9.18.1 Public Perception of Genomic Research
9.18.2 Addressing Fears Surrounding Gene Editing and the “Unknown” Consequences of Modifying Pathogens or Human Genomes
9.18.3 Misinformation and Genomic Research
9.18.4 Building Public Trust in Genomic Research
9.19 Exploring Genomic Approaches in Tropical and Neglected Diseases
9.19.1 Advancements in Genomic Research for Tropical Infectious Diseases
9.19.2 Genomic Innovations for Understanding and Addressing Neglected Diseases
9.20 Ethical, Legal, and Social Implications of Genomic Research
9.20.1 Genetic Privacy and the Protection of Personal Data in Research
9.20.2 Ethical Challenges in Genomic Editing and Pathogen Modification
9.20.3 Addressing Public Concerns Around Genomic Research in Infectious Diseases
9.21 Conclusion
References
10. Genomics of Prenatal and Paediatric Diseases: Early Detection and Intervention
Priyanka and Ayush Madan
10.1 Introduction
10.1.1 Overview of Genomics in Medicine
10.1.2 Importance of Early Detection and Intervention
10.2 Advancements in Genomic Technologies
10.2.1 Whole-Genome Sequencing (WGS)
10.2.2 Non-Invasive Prenatal Testing (NIPT)
10.2.3 Genetic Screening Tools for Paediatric Diseases
10.2.4 Others
10.3 Prenatal Genomic Screening
10.3.1 Used Techniques and Methods
10.3.2 Applications and Benefits of Clinical Usage
10.3.3 Ethical Considerations
10.4 Paediatric Genomics: Early Detection of Genetic Disorders
10.4.1 Common Paediatric Genetic Disorders
10.4.2 Role of Genomics in Preventive Paediatric Care
10.5 Personalized Medicine and Targeted Interventions
10.5.1 Needed Therapeutic Approaches for Desired Results
10.5.2 Impact of Early Genetic Detection on Treatment
10.6 Challenges in Genomic Implementation
10.6.1 Ethical and Psychological Implications of Genomic Implementation
10.6.2 Accessibility and Equity in Genomic Medicine
10.6.3 Cost-Effectiveness of Genomic Screening Programs
10.7 Future Directions and Innovations
10.7.1 Emerging Genomic Technologies
10.7.2 The Role of Artificial Intelligence and Big Data
10.7.3 Genomic Counselling and Education
10.8 Conclusion
10.8.1 The Future of Genomics in Prenatal and Paediatric Medicine
References
11. Integrating Genomic Data into Electronic Health Records (EHRs)
Raju C., Thrisha Lakkireddy, Reddi Mohan Naidu K., Sivasubramanyam Medasani and Bukke Pasunath Naik
11.1 Introduction
11.2 EHRs: Structure and Standards
11.2.1 Data Structure in EHRs
11.2.1.1 Structured Data
11.2.1.2 Unstructured Data
11.2.1.3 Hybrid Data Models
11.2.2 Standardization Protocols
11.2.2.1 Health Level Seven (HL7) Standards
11.2.2.2 Observational Medical Outcomes Partnership (OMOP) Common Data
Model
11.2.2.3 Digital Imaging and Communications in Medicine (DICOM)
11.2.2.4 Logical Observation Identifiers Names and Codes (LOINC)
11.2.2.5 RxNorm
11.2.3 Terminology Standards
11.2.3.1 SNOMED CT (Systematized Nomenclature of Medicine – Clinical Terms)
11.2.3.2 ICD-10 (International Classification of Diseases, 10th Revision)
11.2.3.3 Unified Medical Language System (UMLS)
11.2.4 Interoperability Solutions
11.2.4.1 Semantic Interoperability
11.2.4.2 Syntactic Interoperability
11.2.4.3 Interoperability Frameworks and Networks
11.2.4.4 Application Programming Interfaces (APIs)
11.2.4.5 Health Information Exchanges (HIEs)
11.2.4.6 Cloud-Based Interoperability Solutions
11.3 Genomics and Impact in Medicine
11.4 AI and ML in Integration of Genomic Data in EHRs
11.5 Technical Challenges in Integrating Genetic Data within Current EHRs
11.6 Conclusion
References
12. Genomic Counseling: Navigating the Complexities of Genetic Risk and Inheritance
Mudigubba Manoj Kumar, Queeni Sharoon Melam, Mohammed Azhar Hussain, Vishnuvara V. Tummeeti and Akkiraju Sudheer
12.1 Introduction to Genetic Counseling
12.2 Genetic Risk Assessment
12.3 The Counseling Process
12.4 Applications of Genetic Counseling
Conclusion
References
13. Healthcare Policy and Genomics: Shaping the Future of Health Care Systems
A. Revathi, B. Princy, K. Janani, M. Divya, B. Lokeshwari and P. Saranraj
13.1 Introduction
13.2 Genomic Public Health Care
13.3 COVID-19 Pandemic Healthcare
13.4 Impact of Genomics on Personalized Medicine
13.5 Genomics in Disease Prevention and Public Health
13.6 Integration of Genomics into Healthcare Systems
13.7 Genomic Research for Humans
13.8 AI in Healthcare
13.9 AI Applications in Healthcare
13.9.1 Medical Imaging Analysis
13.9.2 Drug Discovery
13.9.3 Precision Medicine
13.10 Challenges Posed by the Use of AI in Healthcare
13.11 Future Challenges in Healthcare
13.12 Conclusion
References
14. Patient Perspectives and Experiences with Genomic Testing
Safa A. Abdalla
14.1 Introduction
14.2 The Use of Genetic Testing to Screen for Diseases
14.3 Patient Understanding and Knowledge
14.4 Perception of Patients towards Genetic Testing
14.5 Barriers against Pharmacogenomics Testing
14.6 Incidental Findings
14.7 Perceptions towards Prenatal Genetic Testing
14.8 Perception towards Genetic Testing for Cancer
14.9 Perception towards Genetic Testing for Neurological Degenerative and Psychiatric Diseases
14.10 Perception towards Genetic Testing for Other Diseases
14.11 Conclusion
Abbreviations
References
15. Global Prospectives on Genomic Healthcare: Opportunities and Challenges
Shaik Harun Rasheed, Kondapuram Parameshwar, G. Buela Priyanka, Laith Hamza Samein and Ravi Kumar Vakkalagadda
Abbreviations
15.1 Introduction
15.1.1 Scope
15.1.2 Importance and Impact
15.2 Historical Development of Genomic Medicine
15.2.1 Key Milestones
15.3 Current Applications of Genomic Healthcare
15.3.1 Precision Medicine
15.4 Ethical, Legal, and Social Implications of Genomic Healthcare
15.4.1 Privacy and Data Security
15.5 Global Initiatives and Policies in Genomic Healthcare
15.5.1 International Collaborations
15.6 Technological Advancements in Genomic Healthcare
15.6.1 CRISPR-Cas9 Technology
15.7 Challenges and Limitations in Genomic Healthcare
15.7.1 Access and Equity
15.8 Future Directions and Emerging Trends in Genomic Healthcare
15.8.1 Personalized Therapies
15.9 Conclusion
Acknowledgment
References
Index
Back to Top